Resolution of an online meeting of the Siberian, Far Eastern and Southern Federal Districts experts on the results of the EMPEROR-Reduced trial “Therapeutic approaches in heart failure with reduced ejection fraction: the EMPA-REG OUTCOME trial and the EMPEROR-Reduced trial”
Abstract
At the online meeting of experts held on April 24, 2021, the results of the international multicenter trial EMPEROR-Reduced were considered. Taking into account the beneficial cardiovascular and renal outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction (<40%), and improvement in patient survival rates, a number of proposals and recommendations for widespread implementation of the trial results into practice of treating patients with chronic heart failure were adopted.
Read the paper
Related studies
- Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
- Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
- A methodology for assessing deployment trauma and its consequences in OEF/OIF/OND veterans: The TRACTS longitudinal prospective cohort study
- Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study
- Factors Influencing Primary and Secondary Implant Stability—A Retrospective Cohort Study with 582 Implants in 272 Patients
- Electroacupuncture for Painful Diabetic Peripheral Neuropathy: A Multicenter, Randomized, Assessor-Blinded, Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.